51. Prognostic and predictive values of the immunoscore in patients with rectal cancer
- Author
-
Maria-Gabriela Anitei, Mihai Danciu, Patrick Bruneval, Franck Zinzindohoué, Guy Zeitoun, Christine Lagorce, Viorel Scripcariu, Nacilla Haicheur, Anne Berger, Gabriela Bindea, Ana-Maria Todosi, Amos Kirilovsky, Bernhard Mlecnik, Florence Marliot, Jérôme Galon, Franck Pagès, Dan Ferariu, and Jean-Marc Chevallier
- Subjects
Oncology ,Male ,Cancer Research ,medicine.medical_specialty ,Pathology ,CD3 Complex ,Colorectal cancer ,CD3 ,Biopsy ,CD8-Positive T-Lymphocytes ,symbols.namesake ,Internal medicine ,medicine ,Cytotoxic T cell ,Humans ,Lymph node ,Fisher's exact test ,Aged ,Neoplasm Staging ,Aged, 80 and over ,biology ,business.industry ,Rectal Neoplasms ,Radiotherapy Dosage ,Middle Aged ,medicine.disease ,Prognosis ,Combined Modality Therapy ,medicine.anatomical_structure ,Treatment Outcome ,Lymphatic Metastasis ,biology.protein ,symbols ,Immunohistochemistry ,Female ,Neoplasm Recurrence, Local ,business ,Infiltration (medical) ,CD8 - Abstract
Purpose: To determine whether the tumor immune infiltrate, as recently evaluated with the Immunoscore methodology, could be a useful prognostic marker in patients with rectal cancers. Experimental design: The influence of the immune infiltrate on patient's outcome was investigated in patients with or without preoperative chemoradiation therapy (pCRT). The density of total (CD3+) and cytotoxic (CD8+) T lymphocytes was evaluated by immunohistochemistry and quantified by a dedicated image analysis software in surgical specimens of patients with rectal cancer (n = 111) who did not receive pCRT and in tumor biopsies performed before pCRT from additional 55 patients. The results were correlated with tumor recurrence, patient's survival, and response to pCRT. Results: The densities of CD3+ and CD8+ lymphocytes and the associated Immunoscore (from I0 to I4) were significantly correlated with differences in disease-free and overall survival (HR, 1.81 and 1.72, respectively; all P < 0.005). Cox multivariate analysis supports the advantage of the Immunoscore compared with the tumor–node–metastasis (TNM) staging in predicting recurrence and survival (all P < 0.001). Lymph node ratio added information in a prognostic model (all P < 0.05). In addition, high infiltration of CD3+ and CD8+ lymphocytes in tumor biopsies was associated with downstaging of the tumor after pCRT (CD3+ cells; Fisher exact test P = 0.01). Conclusions: The Immunoscore could be a useful prognostic marker in patients with rectal cancer treated by primary surgery. The determination of the immune infiltrate in biopsies before treatment could be a valuable information for the prediction of response to pCRT. Clin Cancer Res; 20(7); 1891–9. ©2014 AACR.
- Published
- 2014